Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-16T19:34:17.650Z Has data issue: false hasContentIssue false

EPA-0451 - Phenylalanine and Tyrosine Concentrations in Euthymic Bipolar Disorder

Published online by Cambridge University Press:  15 April 2020

E. Reininghaus
Affiliation:
Psychiatry, Medical University of Graz, Graz, Austria
R.S. McIntyre
Affiliation:
Mood Disorders Psychopharmacology Unit, University health network University of Toronto, Toronto, Canada\
N. Lackner
Affiliation:
Psychiatry, Medical University of Graz, Graz, Austria
S.A. Bengesser
Affiliation:
Psychiatry, Medical University of Graz, Graz, Austria
A. Birner
Affiliation:
Psychiatry, Medical University of Graz, Graz, Austria
F.T. Fellendorf
Affiliation:
Psychiatry, Medical University of Graz, Graz, Austria
H.P. Kapfhammer
Affiliation:
Psychiatry, Medical University of Graz, Graz, Austria
A. Meinitzer
Affiliation:
Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria
S. Zelzer
Affiliation:
Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria
S.J. Wallner-Liebmann
Affiliation:
Institute of Pathophysiology and Immunology, Medical University of Graz, Graz, Austria
H. Mangge
Affiliation:
Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria
D. Fuchs
Affiliation:
Division of Biological Chemistry Biocenter, Medical University of Innsbruck, Graz, Austria

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Individuals with bipolar disorder (BD) are differentially affected by insulin resistance. Individuals without history of mental disorder with insulin resistance usually have high peripheral concentrations of phenylalanine (PHE) and tyrosine (TYR) together. Catecholamine dysfunction is described to be a state-dependend phenomen in patients suffering from BD. Catecholamines are synthesized from essential amino acids PHE and TYR which are biotransformed to dopamine and subsequently converted to nor/adrenaline. Amino acid dysregulation may be a possible mediator of insulin resistance in BD.

Patients/Methods:

Peripheral PHE and TYR concentrations were investigated in euthymic adults with BD. Amino acid differences between normal and overweight individuals with BD were evaluated and outcomes were correlated with the measures of glucose homeostasis.

Results:

Mean plasma PHE to TYR ratio (PHE/TYR) was at the upper limit of the normal range in the whole sample. Enrolled subjects with PHE/TYR beyond the limits of normal exhibited the highest number of prior affective episodes. Sex-specific differences were noted as overweight BD females showed different profiles than normal-weight women. In the overweight females, PHE and TYR concentrations were significantly higher compared to normal-weight women. Significant correlations were noticed between PHE, TYR and PHE/TYR with insulin/Homeostasis Model of Assessment (HOMA)-IR in the whole sample and the subgroup of BD women.

Conclusion:

These significant differences in gender, amino acid pathways and in correlations with immune marker as well as insulin function have not been reported previously. Taken together, increased levels of PHE in BD should be considered when adjudicating diabetes risk especially in women.

Type
EPW40 - Bipolar Disorders 2
Copyright
Copyright © European Psychiatric Association 2014
Submit a response

Comments

No Comments have been published for this article.